MINHAS LADIWALA: Open Payments
NPI 1568017838 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 10 payments from 6 companies in 2025. Trend: 2023 $367 · 2024 $266 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $99 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Dexcom, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Qelbree, MOUNJARO, GEMTESA, XIFAXAN, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
